Shailendra Dwivedi to Uterine Neoplasms
This is a "connection" page, showing publications Shailendra Dwivedi has written about Uterine Neoplasms.
Connection Strength
0.662
-
Role of TGF-ß signaling in uterine carcinosarcoma. Oncotarget. 2015 Jun 10; 6(16):14646-55.
Score: 0.437
-
Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovary. Gynecol Oncol. 2025 Dec; 203:158-164.
Score: 0.225